DNA-Guided depression care: a game changer for morocco?
NCT ID NCT07480486
First seen Mar 28, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tests whether using a person's genetic information can help doctors choose the most effective antidepressant for major depression. About 570 adults in Morocco will be randomly assigned to either standard care or care guided by a genetic test. The goal is to see if genetic guidance leads to higher remission rates and fewer side effects over 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ar-Razi Psychiatric Hospital, Ibn Sina University Hospital
Rabat, Rabat-Salé-Kénitra, 40000, Morocco
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.